Bladder Cancer
Theories behind Bacillus Calmette-Guérin failure in high-risk non-muscle-invasive bladder cancer and update on current management.
April 15, 2024
Advances in preclinical assessment of therapeutic targets for bladder cancer precision medicine.
April 12, 2024
Predictors of persistent opioid use in bladder cancer patients undergoing radical cystectomy: A SEER-Medicare analysis.
April 11, 2024
Characterization and impact of non-canonical WNT signaling on outcomes of urothelial carcinoma.
April 11, 2024
Dr. Bishoy Faltas Named Chief Research Officer of the Englander Institute for Precision Medicine
April 10, 2024
The Clinical Impact of Delaying Radical Cystectomy in Muscle Invasive Bladder Cancer - Expert Commentary
April 10, 2024
Perioperative complications and in-hospital mortality in radical cystectomy patients with heart-valve replacement.
April 8, 2024
Pharmacologic Properties and Preclinical Activity of Sasanlimab, A High-affinity Engineered Anti-Human PD-1 Antibody.
April 7, 2024